Who is sponsoring NCT01669291?

NCT01669291 is sponsored by Main Line Fertility Center.

What drugs are being tested in NCT01669291?

Interventions: Bravelle and Menopur, Agonist, Antagonist.

What is the status of NCT01669291?

NCT01669291 is currently COMPLETED.

Last reviewed 2014-06-03 · How we verify

Effect of GnRH Antagonist Protocol vs Agonist Long Protocol During Controlled Hyperstimulation (COH)for Assisted Reproduction on IVF Outcome, Peak Estradiol Level, and Duration of Stimulation.

NCT01669291 NA COMPLETED

The purpose of this study is to determine if utilizing GnRH antagonists versus agonist long protocol during controlled ovarian stimulation (COH) with human-derived gonadotropins for assisted reproduction affects IVF outcome, peak estradiol level, and duration of stimulation.

Details

Lead sponsor	Main Line Fertility Center
Phase	NA
Status	COMPLETED
Enrolment	43
Start date	2012-07
Completion	2014-05

Conditions

Fertility

Interventions

Bravelle and Menopur
Agonist
Antagonist

Primary outcomes

To determine if COH in IVF patients using Bravelle & Menopur with antagonists results in improved or equal IVF results compared to patients using agonist. — One year

Countries

United States